Fox Business: ‘Really can’t explain them by natural origin’: Dr. Quay dishes on incongruences in COVID genome

Dr. Steven Quay discusses the lab leak theory and the immune suppressing gene considered a ‘gain-a-function deadly sin’ causing asymptomatic responses on ‘Fox Business Tonight.’

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Dr. Steven Quay is joined by Senator Rand Paul and Richard H. Ebright, Board of Governors professor of chemistry and chemical biology at Rutgers University. They discuss the lab leak theory of COVID-19 in detail.

Dr. Steven Quay testified to the Senate that the coronavirus came from a lab in Wuhan, China. His reasons include the timing of the virus's emergence, research activities at the Wuhan Institute of Virology, and the genomic sequence of the virus. Quay also criticized China's concealment of information and expressed concerns about risky research at the lab.

In a recent conversation on The Vince Coglianese Show, Dr. Steven Quay shares his thoughts on various aspects of the COVID-19 pandemic, shedding light on critical issues ranging from the origins of the virus to the trust deficit in the medical community.